Clinical Trials Browser

Phase 1 × Rhabdomyosarcoma × Gefitinib × Clear all

NCT00132158 2012-04-17

ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors

Phase 1 Completed

Glioblastoma, Neuroblastoma, Rhabdomyosarcoma, Osteosarcoma